Attributes | Values |
---|
rdf:type
| |
Description
| - Autoantibodies against nicotinic acetylcholine receptor (nAChR) in myasthenia gravis (MG) patients are usually detected by radioimmunoprecipitation assays using extracted acetylcholine receptors labeled irreversibly with 125I-alpha-bungarotoxin (alpha-BuTx). We established an assay using nAChRs labeled with Eu(3+)-alpha-cobratoxin (alpha-CTx). Eu(3+)-labeled alpha-CTx competed with 125I- alpha-BuTx for binding to Torpedo nAChRs and saturated the binding sites of human nAChRs, with a K(d) of 7.2 x 10(-9) mol/L. Results of the immunoassay performed with Eu(3+)-labeled alpha-CTx were similar to those obtained with 125I-alpha-BuTx, with a slightly higher limit of detection [0.3 nmol/L (n = 6) vs approximately 0.1 nmol/L for isotopic assay]. None of 34 negative sera tested gave a value >0.3 nmol/L. Of the 35 positive myasthenic sera (with antibody values, previously determined by isotopic assay, of 0.4- 1290 nmol/L) compared in the two assays, 32 tested positive with the Eu(3+) assay. Linear regression ana
- Autoantibodies against nicotinic acetylcholine receptor (nAChR) in myasthenia gravis (MG) patients are usually detected by radioimmunoprecipitation assays using extracted acetylcholine receptors labeled irreversibly with 125I-alpha-bungarotoxin (alpha-BuTx). We established an assay using nAChRs labeled with Eu(3+)-alpha-cobratoxin (alpha-CTx). Eu(3+)-labeled alpha-CTx competed with 125I- alpha-BuTx for binding to Torpedo nAChRs and saturated the binding sites of human nAChRs, with a K(d) of 7.2 x 10(-9) mol/L. Results of the immunoassay performed with Eu(3+)-labeled alpha-CTx were similar to those obtained with 125I-alpha-BuTx, with a slightly higher limit of detection [0.3 nmol/L (n = 6) vs approximately 0.1 nmol/L for isotopic assay]. None of 34 negative sera tested gave a value >0.3 nmol/L. Of the 35 positive myasthenic sera (with antibody values, previously determined by isotopic assay, of 0.4- 1290 nmol/L) compared in the two assays, 32 tested positive with the Eu(3+) assay. Linear regression ana (en)
|
Title
| - Determination of anti-acetylcholine receptor antibodies in myasthenic patients by use of time-resolved fluorescence.
- Determination of anti-acetylcholine receptor antibodies in myasthenic patients by use of time-resolved fluorescence. (en)
|
skos:prefLabel
| - Determination of anti-acetylcholine receptor antibodies in myasthenic patients by use of time-resolved fluorescence.
- Determination of anti-acetylcholine receptor antibodies in myasthenic patients by use of time-resolved fluorescence. (en)
|
skos:notation
| - RIV/67985823:_____/02:20020034!RIV/2003/AV0/A20003/N
|
http://linked.open.../vavai/riv/strany
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(NF4646), Z(AV0Z5011922)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/67985823:_____/02:20020034
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - nicotinic acetylcholine receptor; time-resolved fluorescence method; myasthenia gravis (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - US - Spojené státy americké
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...ocetUcastnikuAkce
| |
http://linked.open...nichUcastnikuAkce
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Říčný, Jan
- Šimková, L.
- Vincent, A.
|
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |